Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2012
11/22/2012US20120296090 Drug Repositioning Methods For Targeting Breast Tumor Initiating Cells
11/22/2012US20120296087 Morpholino-based antisense agent
11/22/2012US20120295938 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/22/2012US20120295921 Pyridyl piperidine orexin receptor antagonists
11/22/2012US20120295907 Insecticidal compounds
11/22/2012US20120295906 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
11/22/2012US20120295905 New anti-malarial agents
11/22/2012US20120295904 Hematopoietic growth factor mimetic small molecule compounds and their uses
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295896 Oxadiazole inhibitors of leukotriene production
11/22/2012US20120295894 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
11/22/2012US20120295891 Novel substituted triazole derivatives as gamma secretase modulators
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295885 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295874 Coferons and methods of making and using them
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120294835 Substituted pyridines and pyrimidines
11/22/2012US20120294803 Cxcr4 antagonists for imaging of cancer and inflammatory disorders
11/22/2012CA2836372A1 Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid
11/22/2012CA2836311A1 Amine derivatives as potassium channel blockers
11/22/2012CA2835835A1 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012CA2835436A1 Parasiticidal dihydroisoxazole compounds
11/22/2012CA2834077A1 Inhibitors of bruton's tyrosine kinase
11/22/2012CA2832384A1 1,3-oxazines as bace1 and/or bace2 inhibitors
11/21/2012EP2524912A1 Amine derivatives
11/21/2012EP2523952A1 Thiazole and oxazole kinase inhibitors
11/21/2012EP2523949A1 Novel substituted triazole derivatives as gamma secretase modulators
11/21/2012EP2523944A1 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
11/21/2012EP2523936A1 Compounds which modulate the cb2 receptor
11/21/2012EP2523665A1 Voltage-gated sodium channel blockers
11/21/2012EP2523560A1 Compounds and methods
11/21/2012CN1763018B Oxazolidinone analog compound
11/21/2012CN102791706A Process for making a metabotropic glutamate receptor positive allosteric modulator-874
11/21/2012CN102791697A Amino-pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
11/21/2012CN102791693A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
11/21/2012CN102791690A Di-substituted pyridine derivatives as anticancers
11/21/2012CN102791688A Estrogen receptor ligands
11/21/2012CN102791687A Novel inhibitors of hepatitis C virus replication
11/21/2012CN102791133A Fungicidal heterocyclic compounds
11/21/2012CN102786516A Method for synthesizing rivaroxaban
11/21/2012CN102786515A 2-(2, 2-dimethyl-2, 3-dihydrobenzofuran-5-group)morpholine and preparation method and application
11/21/2012CN102786512A N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and application thereof to tumor resistance
11/21/2012CN102786488A Preparation method of intermediate for synthesis of micafungin and derivative thereof
11/21/2012CN101903342B Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
11/21/2012CN101687862B Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1h-pyrazol-4-yl)methanone
11/21/2012CN101648902B Dihydropyridine type tumor chemotherapeutic sensitizer and application thereof
11/21/2012CN101137382B Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
11/21/2012CN101018783B Quinoxaline inhibitors of the HEDGEHOG signalling pathway
11/20/2012US8314232 Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide
11/20/2012US8314129 Optical isomers of an iloperidone metabolite
11/20/2012US8314107 Carboxamide compounds and methods for using the same
11/20/2012US8314099 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
11/20/2012US8314097 Organic compounds
11/20/2012US8314095 [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
11/20/2012US8314094 Benzoxazinone derivative
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/20/2012US8314089 Substituted pyrazolamides and their use
11/20/2012US8314087 Nitrogen-containing heterocyclyl ketones and methods of use
11/20/2012CA2700598C Nitrogen-containing heterocyclic compound and pest control agent
11/20/2012CA2693180C Fused bicyclic compound
11/20/2012CA2611530C Tyrosine kinase inhibitors
11/20/2012CA2549675C Oxazolidinone-quinolone hybrid antibiotics
11/20/2012CA2537559C Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
11/20/2012CA2482466C Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
11/15/2012WO2012155066A2 Spiro-oxindole mdm2 antagonists
11/15/2012WO2012154777A1 Hepatitis c virus inhibitors
11/15/2012WO2012154760A1 Fused heterocyclic compounds as sodium channel modulators
11/15/2012WO2012154608A1 Reactive mtor and pi3 kinase inhibitors and uses thereof
11/15/2012WO2012153729A1 Heteroaromatic ring derivative
11/15/2012WO2012153341A1 A process for the preparation of iloperidone and pharmaceutically acceptable salts thereof
11/15/2012WO2012153155A1 Process for the preparation of a rivaroxaban and intermediates formed in said process
11/15/2012WO2012152915A1 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/15/2012WO2012152644A1 Production of dense bodies (db) from hcmv-infected cells
11/15/2012WO2012106534A3 Hiv integrase inhibitors
11/15/2012US20120291159 Azoline Compounds for Combating Invertebrate Pests
11/15/2012US20120289698 Certain heterocycles, compositions thereof, and methods for their use
11/15/2012US20120289697 Novel sulfonic acid derivative compound and novel naphthalic acid derivative compound
11/15/2012US20120289555 Novel S-Nitrosoglutathione Reductase Inhibitors
11/15/2012US20120289551 Mineralocorticoid receptor antagonists
11/15/2012US20120289522 Compounds as lysophosphatidic acid receptor antagonists
11/15/2012US20120289520 Chemical compounds 785
11/15/2012US20120289507 Organic compounds as smo inhibitors
11/15/2012US20120289506 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
11/15/2012US20120289505 Inhibitors of diacylglycerol acyl transferase
11/15/2012US20120289504 Benzoimidazole Compounds and Uses Thereof
11/15/2012US20120289500 Potassium channel modulators
11/15/2012US20120289495 Compounds and methods
11/15/2012US20120289493 Fused heterocyclic compounds as ion channel modulators
11/15/2012US20120289483 Compounds for the treatment of proliferative disorders
11/15/2012US20120288855 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use
11/15/2012US20120288501 Substituted benzazoles and methods of their use as inhibitors of raf kinase
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012DE102011101446A1 Herstellung von "Dense Bodies" (DB) Production of "dense bodies" (DB)
11/15/2012CA2850576A1 Production of "dense bodies" (db) from hcmv-infected cells
11/15/2012CA2835688A1 Hepatitis c virus inhibitors
11/15/2012CA2835422A1 Spiro-oxindole mdm2 antagonists
11/15/2012CA2834712A1 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/15/2012CA2834164A1 Fused heterocyclic compounds as sodium channel modulators
11/14/2012EP2522665A1 Crystalline sodium salt of an HIV integrase inhibitor
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 647